Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (NASD: REGN) shares, but tentative about paying the going market price of $256.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $165 strike, which has a bid at the time of this writing of $16.10. Collecting that bid as the premium represents a 9.8% return against the $165 commitment, or a 5.9% annualized...
Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (NASD: REGN) shares, but tentative about paying the going market price of $256.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $165 strike, which has a bid at the time of this writing of $16.10. Collecting that bid as the premium represents a 9.8% return against the $165 commitment, or a 5.9% annualized...
Share this Article
Recommended